Results of STI571 in chronic myelogenous leukemia (CML) blastic phase.
| . | No. (%) . | ||
|---|---|---|---|
| Parameter . | Myeloid . | Lymphoid and Ph-positive ALL . | Total . |
| No. treated | 33 | 15 | 48 |
| Complete response | 4 (12) | 3 (20) | 7 (15) |
| Marrow complete response | 5 (15) | 6 (40) | 11 (23) |
| Partial response | 15 (45) | 2 (13) | 17 (35) |
| . | No. (%) . | ||
|---|---|---|---|
| Parameter . | Myeloid . | Lymphoid and Ph-positive ALL . | Total . |
| No. treated | 33 | 15 | 48 |
| Complete response | 4 (12) | 3 (20) | 7 (15) |
| Marrow complete response | 5 (15) | 6 (40) | 11 (23) |
| Partial response | 15 (45) | 2 (13) | 17 (35) |